Skip to main content
×
Home
    • Aa
    • Aa

The Flaws and Human Harms of Animal Experimentation

Abstract
Abstract:

Nonhuman animal (“animal”) experimentation is typically defended by arguments that it is reliable, that animals provide sufficiently good models of human biology and diseases to yield relevant information, and that, consequently, its use provides major human health benefits. I demonstrate that a growing body of scientific literature critically assessing the validity of animal experimentation generally (and animal modeling specifically) raises important concerns about its reliability and predictive value for human outcomes and for understanding human physiology. The unreliability of animal experimentation across a wide range of areas undermines scientific arguments in favor of the practice. Additionally, I show how animal experimentation often significantly harms humans through misleading safety studies, potential abandonment of effective therapeutics, and direction of resources away from more effective testing methods. The resulting evidence suggests that the collective harms and costs to humans from animal experimentation outweigh potential benefits and that resources would be better invested in developing human-based testing methods.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The Flaws and Human Harms of Animal Experimentation
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Dropbox account. Find out more about sending content to Dropbox.

      The Flaws and Human Harms of Animal Experimentation
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your Google Drive account. Find out more about sending content to Google Drive.

      The Flaws and Human Harms of Animal Experimentation
      Available formats
      ×
Copyright
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

M Benatar . Lost in translation: Treatment trials in the SOD 1 mouse and in human ALS. Neurobiology Disease 2007;26:113

RJ Wall , M Shani . Are animal models as good as we think? Theriogenology 2008;69:29.

T Hartung , J Zurlo . Food for thought… alternative approaches for medical countermeasures to biological and chemical terrorism and warfare. ALTEX 2012;29:251–60

M Leist , T Hartung . Inflammatory findings on species extrapolations: Humans are definitely no 70-kg mice. Archives in Toxicology 2013;87:563–7

M Jucker . The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nature Medicine 2010;16:1210–14

AL Degryse , WE Lawson . Progress towards improving animal models for IPF. American Journal of Medical Science 2011;341:444–9.

KN Morgan , CT Tromborg . Sources of stress in captivity. Applied Animal Behaviour Science 2007;102:262302

C Lutz , A Well , M Novak . Stereotypic and self-injurious behavior in rhesus macaques: A survey and retrospective analysis of environment and early experience. American Journal of Primatology 2003;60:115

A Akhtar , JJ Pippin , CB Sandusky . Animal models in spinal cord injury: A review. Reviews in the Neurosciences 2008;19:4760.

MR Macleod , T O’Collins , DW Howells , GA Donnan . Pooling of animal experimental data reveals influence of study design and publication bias. Stroke 2004;35:1203–8

JC Crabbe , D Wahlsten , BC Dudek . Genetics of mouse behavior: Interactions with laboratory environment. Science 1999;284:1670–2, at 1670.

E Sena , B van der Worp , D Howells , M Macleod . How can we improve the pre-clinical development of drugs for stroke? Trends in Neurosciences 2007;30:433–9.

M Fisher , G Feuerstein , DW Howells , PD Hurn , TA Kent , SI Savitz , et al. Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 2009;40:2244–50.

S Perrin . Preclinical research: Make mouse studies work. Nature 2014;507:423–5

DM Morales , N Marklund , D Lebold , HJ Thompson , A Pitkanen , WL Maxwell , et al. Experimental models of traumatic brain injury: Do we really need a better mousetrap? Neuroscience 2005;136:971–89

YE Xiong , A Mahmood , M Chopp . Animal models of traumatic brain injury. Nature Reviews Neuroscience 2013;14:128–42

AI Maas , B Roozenbeek , GT Manley . Clinical trials in traumatic brain injury: Past experience and current developments. Neurotherapeutics 2010;7:115–26.

J Seok , HS Warren , AG Cuenca , MN Mindrinos , HV Baker , W Xu , et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proceedings of the National Academy of Sciences USA 2013;110:3507–12.

DO Wiebers , HP Adams , JP Whisnant . Animal models of stroke: Are they relevant to human disease? Stroke 1990;21:13.

N Lonjon , M Prieto , H Haton , CB Brøchner , L Bauchet , V Costalat , et al. Minimum information about animal experiments: Supplier is also important. Journal of Neuroscience Research 2009;87:403–7.

JS Mogil , SG Wilson , K Bon , SE Lee , K Chung , P Raber , et al. Heritability of nociception I: Responses of 11 inbred mouse strains on 12 measures of nociception. Pain 1999;80:6782.

DF Horrobin . Modern biomedical research: An internally self-consistent universe with little contact with medical reality? Nature Reviews Drug Discovery 2003;2:151–4.

S Vassilopoulous , C Esk , S Hoshino , BH Funke , CY Chen , AM Plocik , et al. A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism. Science 2009;324:1192–6.

E Guttman-Yassky , JG Krueger . Psoriasis: Evolution of pathogenic concepts and new therapies through phases of translational research. British Journal of Dermatology 2007;157:1103–15

E Lane , S Dunnett . Animal models of Parkinson’s disease and L-dopa induced dyskinesia: How close are we to the clinic? Psychopharmacology 2008;199:303–12.

MI Johnston , AS Fauci . An HIV vaccine—evolving concepts. New England Journal of Medicine 2007;356:2073–81.

RJ Hogan . Are nonhuman primates good models for SARS? PLoS Medicine 2006;3:1656–7

J Bailey . Non-human primates in medical research and drug development: A critical review. Biogenic Amines 2005;19:235–55.

R Lemon , SB Dunnett . Surveying the literature from animal experiments: Critical reviews may be helpful—not systematic ones. BMJ 2005;330:977–8.

T Koppanyi , MA Avery . Species differences and the clinical trial of new drugs: A review. Clinical Pharmacology and Therapeutics 1966;7:250–70

SS Schneierson , E Perlman . Toxicity of penicillin for the Syrian hamster. Proceedings of the Society for Experimental Biology and Medicine 1956;91:229–30.

RAJ Mathews . Medical progress depends on animal models—doesn’t it? Journal of the Royal Society of Medicine 2008;101:95–8.

N Shanks , R Greek , J Greek . Are animal models predictive for humans? Philosophy, Ethics, and Humanities in Medicine 2009;4:2

U. Dirnagl Bench to bedside: The quest for quality in experimental stroke research. Journal of Cerebral Blood Flow & Metabolism 2006;26:1465–78

HB van der Worp , DW Howells , ES Sena , MJ Poritt , S Rewell , V O’Collins , et al. Can animal models of disease reliably inform human studies? PLoS Medicine 2010;7:e1000245

MM Wang , X Guohua , RF Keep . Should the STAIR criteria be modified for preconditioning studies? Translational Stroke Research 2013;4:314

VE O’Collins , MR Macleod , GA Donnan , LL Horky , BH van der Worp , DW Howells . 1,026 experimental treatments in acute stroke. Annals of Neurology 2006;59:467–7

BJ Traynor , L Bruijn , R Conwit , F Beal , G O’Neill , SC Fagan , et al. Neuroprotective agents for clinical trials in ALS: A systematic assessment. Neurology 2006;67:20–7

G. Sinha Another blow for ALS. Nature Biotechnology 2013;31:185

LS Schneider , F Mangialasche , N Andreasen , H Feldman , E Giacobini , R Jones , et al. Clinical trials and late-stage drug development in Alzheimer’s disease: An appraisal from 1984 to 2014. Journal of Internal Medicine 2014;275:251–83

DT Odom , RD Dowell , ES Jacobsen , W Gordon , TW Danford , KD MacIsaac , et al. Tissue-specific transcriptional regulation has diverged significantly between human and mouse. Nature Genetics 2007;39:730–2

A. Tonks The quest for the AIDs vaccine. BMJ 2007;334:1346–8

CA Lemere . Developing novel immunogens for a safe and effective Alzheimer’s disease vaccine. Progress in Brain Research 2009;175:83

H. Attarwala TGN1412: From discovery to disaster. Journal of Young Pharmacists 2010;2:332–6

I Roberts , I Kwan , P Evans , S. Haig Does animal experimentation inform human health care? Observations from a systematic review of international animal experiments on fluid resuscitation. BMJ 2002;324:474–6

R. Heywood Target organ toxicity. Toxicology Letters 1981;8:349–58

R Greek , J. Greek Animal research and human disease. JAMA 2000;283:743–4

F. Sams-Dodd Strategies to optimize the validity of disease models in the drug discovery process. Drug Discovery Today 2006;11:355–63

J. Zurlo No animals harmed: Toward a paradigm shift in toxicity testing. Hastings Center Report 2012;42 Suppl:s23–6

R Greek , J. Greek Is the use of sentient animals in basic research justifiable? Philosophy, Ethics, and Humanities in Medicine 2010;5:14

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Cambridge Quarterly of Healthcare Ethics
  • ISSN: 0963-1801
  • EISSN: 1469-2147
  • URL: /core/journals/cambridge-quarterly-of-healthcare-ethics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 489
Total number of PDF views: 1327 *
Loading metrics...

Abstract views

Total abstract views: 1951 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 26th June 2017. This data will be updated every 24 hours.